Artelo Biosciences Inc (NAS:ARTL)
$ 1.1152 -0.004 (-0.36%) Market Cap: 3.60 Mil Enterprise Value: -1.88 Mil PE Ratio: 0 PB Ratio: 0.49 GF Score: 37/100

Artelo Biosciences Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript

Feb 22, 2023 / 02:00PM GMT
Release Date Price: $3.02 (-0.98%)
Operator

Good day, ladies and gentlemen, and welcome to the third annual Winter Wonderland Best Ideas Virtual Investor Conference. Next presenting company is Artelo Biosciences, Inc. (Conference Instructions)

I'd now like to turn the floor over to today's host, Gregory Gorgas, who is the CEO and President of Artelo Biosciences, Inc. Please go ahead.

Unidentified Analyst

Thank you, [Olie], and thank you to all who have joined us here at the Winter Wonderland. I'm going to be able to share with you over the next 20 minutes or so about Artelo Biosciences and the progress we've been making. We are on the Nasdaq under the symbol ARTL.

I will be making some forward-looking statements. We would ask all investors to please go to our website at artelobio.com, where all of the company's SEC filings are available. Today, we are going to talk through five main opportunities or pillars for Artelo Biosciences. We're a clinical-stage biopharmaceutical company. And we're focused in on modulating the endocannabinoid system through lipids signaling, with a focus on cancer and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot